Poster 10
Tapinarof Cream 1% Once Daily for the Treatment of Moderate to Severe Atopic Dermatitis in Children and Adults: The Pivotal Phase 3 ADORING
top of page
DERM2022 POSTERS
We invite you to view the DERM2022 Posters. The posters are categorized by disease state.
Click on the disease state below to view all posters in that category.
Poster 11
Racial and Ethnic Differences in Sociodemographic and Treatment Characteristics Among Patients with Atopic Dermatitis in the United States:
9 views
Poster 12
Efficacy and Safety of Lebrikizumab in Moderate-to-Severe Atopic Dermatitis: Results from Two Phase 3, Randomized, Double-Blinded, Placebo-C
7 views
Poster 13
Efficacy and Safety of Lebrikizumab in Combination with Topical Corticosteroids in Patients with Moderate-to-Severe Atopic Dermatitis...
4 views
Poster 14
Post-hoc Analyses of Lebrikizumab Phase 3 Trials (LAVOLTA I and II): Enhanced Efficacy in Patients with Prior Exacerbations and Elevated...
5 views
Poster 15
Lebrikizumab Allows Interleukin (IL)-13 Membrane Binding and Subsequent Internalization through IL-13 Receptor Alpha 2 (Ra2) [IL-13 decoy...
8 views
Poster 16
Comparison of the Affinity and in vitro Activity of Lebrikizumab, Tralokinumab, and Cendakimab
5 views
Poster 17
Clinically meaningful responses achieved with tralokinumab in adults with moderate-to-severe atopic dermatitis who did not meet IGA 0/1...
4 views
Poster 18
Efficacy and safety of tralokinumab plus topical corticosteroids in patients with severe atopic dermatitis and prior history of dupilumab...
6 views
Poster 19
Long-term improvements in disease severity, itch, and quality of life after 3 years of tralokinumab treatment in adults...
5 views
Poster 20
Efficacy and Safety of Dupilumab in Children Aged ≥6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis
8 views
Poster 21
Dupilumab Treatment Normalizes Skin Barrier Function and Improves Clinical and Patient-Reported Outcomes in Patients...
7 views
Poster 22
Improvement in Disease Severity and Quality of Life in Patients With Atopic Dermatitis Treated With Dupilumab for up to 18 Months...
4 views
Search by
Poster
Number
bottom of page